Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria (RALPIR)
This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Fritz Bredeek, MD, PhD, Metropolis Medical
First received: January 6, 2010
Last updated: October 25, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2011|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|